Picture of Median Technologies SA logo

ALMDT Median Technologies SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Median Technologies FY Revenue Drops To 22.2 Million Euros

Jan 29 (Reuters) - Median Technologies SA  ALMDT.PA :
    * 2023 REVENUE: EUR 22.2M, BELOW 2022 REVENUE.
    * COMPANY CASH HORIZON: Q2 2025.
    * ORDER BACKLOG AT ALL-TIME HIGH OF €66.9M
    * ARE TARGETING FDA 510(K) CLEARANCE FOR CADE/CADX SOFTWARE
AS
MEDICAL DEVICE EYONIS™ LCS IN Q1 2025, FOLLOWED BY LAUNCH FOR US
LUNG CANCER SCREENING MARKET, WHICH COVERS 14.5 MILLION PEOPLE
WITH AN EXISTING REIMBURSEMENT PER PROCEDURE OF $650
    * Q4 2023 REVENUE TOTALED €5.3M, ABOVE THE €5.1M GENERATED
IN THE
SAME PERIOD IN 2022.
    * EXPECT TO RETURN TO GROWTH IN 2024 ON BACK OF A DECLINE IN
2023
REVENUE DUE TO SOFT ORDER INTAKE IN CHINA CAUSED BY COVID
LOCKDOWNS IN 2022 AND H1 2023
    * 2024 STRATEGIC OUTLOOK AND KEY MILESTONES: SCALE UP THE
ICRO
CORE BUSINESS, WITH DOUBLE DIGIT GROWTH PROPELLED BY A RECOVERY
IN CHINA AND AN ACCELERATION IN US BUSINESS.

Source text for Eikon:  ID:nBwCJfzMa 
Further company coverage:  ALMDT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Median Technologies SA

See all news